Melanopsin-Driven Pupil Response and Light Exposure in Non-seasonal Major Depressive Disorder

被引:17
|
作者
Feigl, Beatrix [1 ,2 ,3 ]
Ojha, Govinda [1 ,2 ]
Hides, Leanne [4 ]
Zele, Andrew J. [1 ,5 ]
机构
[1] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Med Retina & Visual Sci Labs, Brisbane, Qld, Australia
[2] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[3] Queensland Eye Inst, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia
[5] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia
来源
FRONTIERS IN NEUROLOGY | 2018年 / 9卷
基金
澳大利亚研究理事会;
关键词
pupil; melanopsin; light exposure; depression; MDD = major depressive disorder; RETINAL GANGLION-CELLS; PHOTOTRANSDUCTION; ARCHITECTURE; PROJECTIONS; REFLEX; MOOD;
D O I
10.3389/fneur.2018.00764
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Melanopsin-expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) signal non-imaging forming effects of environmental light for circadian phoentrainment, the pupil light reflex, and mood regulation. In seasonal affective disorder, ipRGC dysfunction is thought to cause abberant transmission of the external illumination for photoentrainment. It is not known if patients with non-seasonal depression have abnormal melanospin mediated signaling and/or irregular environmental light exposure. Methods: Twenty-one adults who live in a sub-tropical region, including eight patients with non-seasonal depression and thirteen age-matched healthy controls were recruited. The Mini International Neuropsychiatry Interview diagnosed the presence of a major depressive disorder. Light exposure was determined using actigraphy over a 2 week period. The melanopsin mediated post-illumination pupil response (PIPR) and outer retinal inputs to ipRGCs (transient pupil response and maximum pupil constriction amplitude) were measured in response to 1 s, short and long wavelength light with high and low melanopsin excitation. Results: The mean daylight exposure as a function of clock hours and total light exposure duration (mins) to illumination levels commonly recommended for depression therapy were not significantly different between groups. Out of 84 pupil measurements (42 each in the depression and control groups), the melanopsin-mediated PIPR amplitude, transient pupil response, and pupil constriction amplitude were not significantly different between groups. Conclusions: This report provides initial evidence of normal melanopsin function and environmental light exposures in patients with pre-dominately mid and moderate non-seasonal depression in a subtropical location in the southern hemisphere.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD?
    Abramowitz, JS
    Foa, EB
    BEHAVIOR THERAPY, 2001, 31 (04) : 795 - 800
  • [32] Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder
    Yehuda, R
    Halligan, SL
    Golier, JA
    Grossman, R
    Bierer, LM
    PSYCHONEUROENDOCRINOLOGY, 2004, 29 (03) : 389 - 404
  • [33] Intensive Exposure and Response Prevention for Adolescent Body Dysmorphic Disorder With Comorbid Obsessive-Compulsive Disorder and Major Depressive Disorder
    Le, Thien-An P.
    Merricks, Katie
    Nadeau, Joshua M.
    Ramos, Amaya
    Storch, Eric A.
    CLINICAL CASE STUDIES, 2017, 16 (06) : 480 - 496
  • [34] Adjunctive bright light in non-seasonal major depression:: results from patient-reported symptom and well-being scales
    Martiny, K
    Lunde, M
    Undén, M
    Dam, H
    Bech, P
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 (06) : 453 - 459
  • [35] Exposure-response Modeling From the CLARITY Trial of Pimavanserin for Adjunctive Treatment of Major Depressive Disorder
    Darwish, Mona
    Dirks, Bryan
    Passarell, Julie
    Jaworowicz, David
    Bihorel, Sebastien
    Howell, Becky
    Owen, Joel
    DeKarske, Daryl
    Stankovic, Srdjan
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 463 - 474
  • [36] Response to Treatment with Placebo, Medication or Psychotherapy in Severe Non-Psychotic Major Depressive Disorder
    Dunlop, Boadie W.
    Aaron, Margo H.
    CURRENT PSYCHIATRY REVIEWS, 2010, 6 (01) : 28 - 45
  • [37] Non-linear EEG analyses predict non-response to rTMS treatment in major depressive disorder
    Arns, Martijn
    Cerquera, Alexander
    Gutierrez, Rafael M.
    Hasselman, Fred
    Freund, Jan A.
    CLINICAL NEUROPHYSIOLOGY, 2014, 125 (07) : 1392 - 1399
  • [38] Pupillary response to blue light as a biomarker of seasonal pattern in Major Depressive Episode: A clinical study using pupillometry
    Maruani, Julia
    Vissouze, Lily
    Hebert, Marc
    Rach, Heloise
    Zehani, Feriel
    Lejoyeux, Michel
    Bourgin, Patrice
    Geoffroy, Pierre A.
    PSYCHIATRY RESEARCH, 2025, 344
  • [39] The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder
    Dording, Christina M.
    Sinicropi-Yao, Lara
    Papakostas, George
    Matthews, John D.
    Nierenberg, Andrew A.
    Fava, Maurizio
    Mischoulon, David
    NORDIC JOURNAL OF PSYCHIATRY, 2009, 63 (05) : 420 - 425
  • [40] Data-driven clustering of cortical thickness reveals stable major depressive disorder biotypes associated with treatment response
    Jollans, L.
    Saemann, P.
    Brueckl, T.
    Binder, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S256 - S256